Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study
Bibliographic record
Abstract
BACKGROUND: This study assessed the real-world effectiveness of the ChAdOx1 nCoV-19 vaccine in adults against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, symptomatic infection, and severe coronavirus disease 2019 (COVID-19) during periods of Beta and Delta variant dominance in Qatar. METHODS: A national, matched, test-negative case-control study was conducted using 186,130 PCR-positive tests (cases) and 667,289 PCR-negative tests (controls) collected between January 1 and December 18, 2021. Subgroup analyses were performed to evaluate vaccine effectiveness across key strata. RESULTS: The median time between the first and second doses was 61 days (interquartile range, 56-64 days). Two-dose primary-series effectiveness was 66.0% (95% CI, 55.1-74.3%) against any SARS-CoV-2 infection and 73.0% (95% CI, 44.1-87.0%) against symptomatic infection. Effectiveness was estimated at 100% (95% CI, 64.0-100%) against any Beta variant infection and 65.3% (95% CI, 54.2-73.8%) against any Delta infection. Protection against any infection of any variant peaked at 78.4% (95% CI, 50.7-90.5%) within the first month after the second dose, gradually declining to 45.6% (95% CI, 5.5-68.7%) after 150 days. Effectiveness against severe, critical, or fatal COVID-19, irrespective of variant, was 100% (95% CI, 49.3-100%), with no vaccinated individuals progressing to severe, critical, or fatal disease after infection. Effectiveness of a single dose was 59.9% (95% CI, 51.0-67.3%) against any infection-65.0% (95% CI, 49.7-75.6%) against Beta and 55.9% (95% CI, 43.8-65.5%) against Delta-78.4% (95% CI, 60.9-88.0%) against symptomatic infection, and 100% (95% CI, 88.9-100%) against severe, critical, or fatal COVID-19. CONCLUSION: The ChAdOx1 nCoV-19 vaccine provided substantial protection against infection and strong protection against severe outcomes during periods dominated by the Beta and Delta variants, although protection against infection waned within the first few months following the primary series.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.003 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".